Article
Histopathology and proteomics are synergistic for High-Grade Serous Ovarian Cancer platinum response prediction
2024-08-09
Abstract excerpt
<title>Abstract</title> <p>Patients with High-Grade Serous Ovarian Cancer (HGSOC) exhibit varied responses to treatment, with 20–30% showing <italic>de novo</italic> resistance to platinum-based chemotherapy. While hematoxylin-eosin (H&E) pathological slides are used for routine diagnosis of cancer type, they may also contain diagnostically useful information about treatment response. Our study demonstrates that...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- cd5fee24-d970-5b7f-b3c8-bffb6dfaaf56
- DOI
- 10.21203/rs.3.rs-4490790/v1
